作者: Savina Malancona , Monica Donghi , Marco Ferrara , Josè I. Martin Hernando , Marco Pompei
DOI: 10.1016/J.BMC.2010.03.024
关键词:
摘要: Chronic hepatitis C virus (HCV) infections are a significant medical problem worldwide. The NS5B Polymerase of HCV plays central role in replication and is prime target for the discovery new treatment options. We recently disclosed 1H-benzo[de]isoquinoline-1,3(2H)-diones as allosteric inhibitors Polymerase. Structural SAR information guided us modification core structure leading to templates with improved activity toxicity/activity window.